Your browser doesn't support javascript.
loading
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada.
Skowronski, Danuta M; Febriani, Yossi; Ouakki, Manale; Setayeshgar, Solmaz; El Adam, Shiraz; Zou, Macy; Talbot, Denis; Prystajecky, Natalie; Tyson, John R; Gilca, Rodica; Brousseau, Nicholas; Deceuninck, Geneviève; Galanis, Eleni; Fjell, Chris D; Sbihi, Hind; Fortin, Elise; Barkati, Sapha; Sauvageau, Chantal; Naus, Monika; Patrick, David M; Henry, Bonnie; Hoang, Linda M N; De Wals, Philippe; Garenc, Christophe; Carignan, Alex; Drolet, Mélanie; Jassem, Agatha N; Sadarangani, Manish; Brisson, Marc; Krajden, Mel; De Serres, Gaston.
Affiliation
  • Skowronski DM; BC Centre for Disease Control, Communicable Diseases and Immunization Services, Vancouver, British Columbia, Canada.
  • Febriani Y; University of British Columbia, School of Population and Public Health, Vancouver, British Columbia, Canada.
  • Ouakki M; Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, Quebec, Canada.
  • Setayeshgar S; Institut National de Sante Publique du Québec, Biological and Occupational Risks, Quebec City, Quebec, Canada.
  • El Adam S; BC Centre for Disease Control, Communicable Diseases and Immunization Services, Vancouver, British Columbia, Canada.
  • Zou M; BC Centre for Disease Control, Communicable Diseases and Immunization Services, Vancouver, British Columbia, Canada.
  • Talbot D; BC Centre for Disease Control, Data and Analytics Services, Vancouver, British Columbia, Canada.
  • Prystajecky N; Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, Quebec, Canada.
  • Tyson JR; Laval University, Department of Social and Preventive Medicine, Faculty of Medicine, Quebec City, Quebec, Canada.
  • Gilca R; BC Centre for Disease Control, Public Health Laboratory, Vancouver, British Columbia, Canada.
  • Brousseau N; University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, British Columbia, Canada.
  • Deceuninck G; BC Centre for Disease Control, Public Health Laboratory, Vancouver, British Columbia, Canada.
  • Galanis E; Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, Quebec, Canada.
  • Fjell CD; Institut National de Sante Publique du Québec, Biological and Occupational Risks, Quebec City, Quebec, Canada.
  • Sbihi H; Laval University, Department of Social and Preventive Medicine, Faculty of Medicine, Quebec City, Quebec, Canada.
  • Fortin E; Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, Quebec, Canada.
  • Barkati S; Institut National de Sante Publique du Québec, Biological and Occupational Risks, Quebec City, Quebec, Canada.
  • Sauvageau C; Laval University, Department of Social and Preventive Medicine, Faculty of Medicine, Quebec City, Quebec, Canada.
  • Naus M; Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, Quebec, Canada.
  • Patrick DM; BC Centre for Disease Control, Communicable Diseases and Immunization Services, Vancouver, British Columbia, Canada.
  • Henry B; University of British Columbia, School of Population and Public Health, Vancouver, British Columbia, Canada.
  • Hoang LMN; BC Centre for Disease Control, Public Health Laboratory, Vancouver, British Columbia, Canada.
  • De Wals P; University of British Columbia, School of Population and Public Health, Vancouver, British Columbia, Canada.
  • Garenc C; BC Centre for Disease Control, Data and Analytics Services, Vancouver, British Columbia, Canada.
  • Carignan A; Institut National de Sante Publique du Québec, Biological and Occupational Risks, Quebec City, Quebec, Canada.
  • Drolet M; Laval University, Department of Social and Preventive Medicine, Faculty of Medicine, Quebec City, Quebec, Canada.
  • Jassem AN; Université de Montréal, Département de Microbiologie, Infectiologie et Immunologie, Montreal, Quebec, Canada.
  • Sadarangani M; McGill University, Department of Medicine, Division of Infectious Diseases, McGill University Health Center, Montreal, Quebec, Canada.
  • Brisson M; Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, Quebec, Canada.
  • Krajden M; Institut National de Sante Publique du Québec, Biological and Occupational Risks, Quebec City, Quebec, Canada.
  • De Serres G; Laval University, Department of Social and Preventive Medicine, Faculty of Medicine, Quebec City, Quebec, Canada.
Clin Infect Dis ; 75(11): 1980-1992, 2022 11 30.
Article in En | MEDLINE | ID: mdl-35438175
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Adult / Child / Humans Country/Region as subject: America do norte Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2022 Document type: Article Affiliation country: Canada Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Adult / Child / Humans Country/Region as subject: America do norte Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2022 Document type: Article Affiliation country: Canada Country of publication: United States